, and polymyositis (PM) [11, 12] . Our retrospective survey of the seroprevalence of HTLV-1 among patients with PM in Kagoshima, an area of southern Japan where HTLV-1 is endemic, found a rate of HTLV-1 antibody positivity among patients with PM that was significantly higher than the rate in the general population [12] . Therefore, it is possible that HTLV-1 is causally related to the pathogenesis of polymyositis in HTLV-1-seropositive individuals. We have reported elsewhere that the principal HTLV-1 harboring cells in the muscle lesions of HTLV-1 PM are CD4 ϩ T cells [13] , which suggests that HTLV-1 PM is not due to direct viral infection of the muscle fibers but rather Idiopathic PM is thought to be an autoimmune disease caused by T lymphocytes that infiltrate muscles and destroy HLA class I-expressing muscle fibers [14] [15] [16] . Immunohistochemical studies of patients with PM have demonstrated that the majority of infiltrating lymphocytes are CD8 ϩ ab T cells, whereas in dermatomyositis (DM), the infiltrates are mainly perivascular and consist predominantly of CD4 ϩ T cells [17] . Moreover, recently reported findings from studies using T cell receptor (TCR) spectratyping analysis show that severe perturbations of the peripheral T cell repertoire were observed in the blood of patients with PM but not of those with DM [18] . These findings indicate that the pathogenesis of PM and DM is different and support the hypothesis that PM, but not DM, is an autoimmune CD8 ϩ T cell-mediated disease [15] . However, because many attempts to identify viral target antigens or related antigens in muscle fibers of patients with PM have failed, it is now believed that the epitope recognized by muscle-infiltrating lymphocytes (MILs) is a muscle-derived autoantigen [14] [15] [16] 19] .
to a T cell-mediated immunologic process initiated by HTLV-1 infection.
Idiopathic PM is thought to be an autoimmune disease caused by T lymphocytes that infiltrate muscles and destroy HLA class I-expressing muscle fibers [14] [15] [16] . Immunohistochemical studies of patients with PM have demonstrated that the majority of infiltrating lymphocytes are CD8 ϩ ab T cells, whereas in dermatomyositis (DM), the infiltrates are mainly perivascular and consist predominantly of CD4 ϩ T cells [17] . Moreover, recently reported findings from studies using T cell receptor (TCR) spectratyping analysis show that severe perturbations of the peripheral T cell repertoire were observed in the blood of patients with PM but not of those with DM [18] . These findings indicate that the pathogenesis of PM and DM is different and support the hypothesis that PM, but not DM, is an autoimmune CD8 ϩ T cell-mediated disease [15] . However, because many attempts to identify viral target antigens or related antigens in muscle fibers of patients with PM have failed, it is now believed that the epitope recognized by muscle-infiltrating lymphocytes (MILs) is a muscle-derived autoantigen [14] [15] [16] 19] .
On the other hand, data from our recent study suggest that HTLV-1 Tax11-19 immunodominant peptide-specific cells are clonally expanded both in peripheral blood mononuclear cells (PBMC) of healthy HTLV-1 carriers and PBMC of patients with HAM/TSP [20] . Because the antiviral immune response also can cause local tissue damage, as has been demonstrated in the brain lesions of mice infected with the lymphocytic choriomeningitis virus [21] and for the liver necrosis associated with hepatitis B virus infection in humans [22] , we studied the T cells from patients with HTLV-1 PM in both MILs and PBMC and compared them with those from patients with PM and patients with DM. In this study, we analyzed the phenotype of MILs and the repertoire and clonotype of b-chain variable region (Vb) segments both from MILs and PBMC from 3 patients with HTLV-1 PM (including 1 HLA-A*02-positive patient), using muscle biopsy and blood specimens obtained at the same time. Our results show that MILs from patients with HTLV-1 PM contain both CD4 ϩ and CD8 ϩ T cells and demonstrate a complementarity-determining region 3 (CDR3)-dependent expansion of particular Vb segments in muscles. Some of these clonotypes were exactly the same as those observed in CD8 ϩ PBMC, including 1 clonotype that is derived from HLA-A*02/Tax11-19 tetramer-positive cells.
Patients, Materials, and Methods
Patients and blood and muscle biopsy specimens. Peripheral blood was obtained from 2 HTLV-1-seropositive patients with clinical diagnoses of PM. All of these patients were from Kagoshima, where HTLV-1 infection is endemic. Fresh PBMC were obtained by Histopaque-1077 (Sigma) density gradient centrifugation and washed 3 times with PBS containing 1% fetal calf serum (FCS). Muscle biopsy specimens were obtained and processed for staining with hematoxylin-eosin and other routine histochemical stains (Gomori trichrome, ATPase, NADH-tetrazolium reductase, periodic acid-Schiff, and oil red O) for diagnosis.
HLA-A*02 typing and HLA-A*02/Tax11-19 tetramer. Sequence-specific primer polymerase chain reaction (PCR) was done to detect HLA-A*02, as described elsewhere [23] . Phycoerethrin (PE)-conjugated HLA-A*02/Tax11-19-specific tetramer was prepared as described elsewhere [24] .
Immunohistochemical analysis. Immunohistochemical staining of muscle specimens was performed on frozen sections, using a standard avidin-biotin immunoperoxidase procedure, as described elsewhere [25] . The monoclonal antibodies to lymphocyte surface antigens used comprised a 1:200 dilution of CD3, a 1:50 dilution of CD4, and a 1:50 dilution of CD8 (DAKO). Biotinylated antimouse IgG was used as a secondary antibody, and the avidinbiotin-peroxidase complex (ABC) method was used for signal detection (ABC kit; Vector Laboratories).
Isolation of CD4 ϩ , CD8 ϩ , and HLA-A*02/Tax11-19 tetramer- 1 ϫ 10 or CD8 ϩ cells using a High Pure mRNA extraction kit (Boehringer Mannheim). First-strand cDNA was transcribed with oligo(dT) primer and avian myeloblastosis virus reverse transcriptase (RT) by use of a first-strand cDNA synthesis kit (Boehringer Mannheim) in a total volume of 42 mL. All reaction procedures were performed as suggested by the manufacturers.
TCR RT-PCR analysis. Of 42 mL of cDNA solution, 1 mL was used as a template in 50-mL RT-PCRs containing 20 pmol of 1 of a panel of 26 TCR Vb-specific primers and 20 pmol of a reverse primer specific for the TCR b-chain constant region, of which 3 pmol had been end-labeled with 6-FAM (PE-Applied Biosystems), as described elsewhere [20] . PCR was performed using Takara Taq DNA polymerase and an Astec PC-801 thermal cycler. PCR conditions were as follows: denaturation at 94ЊC for 30 s, annealing at 60ЊC for 30 s, and elongation at 72ЊC for 60 s, repeated for 35 cycles and followed by a 10-min extension cycle at 72ЊC. In preliminary experiments, the number of cycles was varied from 25 to 50 to determine the appropriate number of cycles for a semiquantitative PCR (data not shown). The fluorescence intensity of each band was quantified using Genescan software (PE-Applied Biosystems).
TCR spectratyping. CDR3 length spectratyping was performed as described elsewhere [26] . Two microliters of the final PCR mixture was subjected to electrophoresis on a 5% polyacrylamide sequencing gel, and the resulting bands were quantified by fluorescence detection on an automated sequencer (377A DNA sequencer; PE-Applied Biosystems). The repertoire profile was analyzed using Genescan software.
Cloning and sequencing of rearranged TCR Vb transcripts. TCR Vb PCR products were separated onto 1% agarose gels and visualized with ethidium bromide. The purified PCR products were cloned with a Zero Blunt TOPO PCR Cloning Kit (Invitrogen).
Sequencing was performed using an ABI Prism DyeDeoxy Terminator cycle sequencing kit (PE-Applied Biosystems) and a 377A DNA sequencer. The identities of TCR gene family sequences obtained here were established by comparison with published sequences.
Sequence accession numbers. All TCR sequence data have been deposited in the European Molecular Biology Laboratory, the DNA DataBank of Japan, and GenBank (accession nos. AB076747-AB076799).
Results

Infiltration of T cells into muscle specimens from patients with HTLV-1 PM.
Histological examination of muscle specimens from patients with HTLV-1 PM showed infiltration of T cells into endomysium; a representative result is shown in figure 1 . Immunohistochemical studies using monoclonal antibodies against CD4 and CD8 demonstrated that the infiltrating cells contain both CD4 ϩ and CD8 ϩ T cells and that CD4 ϩ T cells outnumbered CD8 ϩ T cells in all patients examined (table 1) .
Use of a restricted set of TCR Vb gene segments by muscleinfiltrating T cells.
To determine whether antigenic stimulation could be involved in the recruitment, activation, and expansion of T cells in the muscle tissue of patients with HTLV-1 PM, we first looked for a preferential use of particular TCR Vb segments by MILs in 3 patients. We compared the TCR Vb repertoire used in MILs, CD4 ϩ T cells, and CD8 ϩ T cells by semiquantitative PCR analysis of TCR Vb transcripts belonging to 26 TCR Vb families. For 1 HLA-A*02-positive patient (HTLV-1 PM3), we compared the TCR Vb repertoire used in MILs, HLA-A*02/Tax11-19 tetramer-positive cells, and whole PBMC (but not in CD4 ϩ or CD8 ϩ cells, because of the limited size of the blood samples). As shown in figure 2, a comparison of the TCR Vb repertoire from the MILs, CD4 ϩ T cells, and CD8
ϩ T cells of patients with HTLV-1 PM showed that the TCR Vb repertoire of MILs from these patients was highly restricted. Vb2, Vb3, and Vb6 were detected in MILs from all patients tested.
Oligoclonal expansion of MILs from patients with HTLV-1 PM. Next, to test whether the MILs in these 3 patients were related to the frequent clonal expansion of CD8 ϩ T cells observed in HTLV-1-infected individuals, we compared the TCR Vb junctional diversity present in the MILs and in the CD8 ϩ T cells by TCR spectratyping analysis. In the spectratype generated from most PBMC, CD4 ϩ T cells, or CD8 ϩ T cells from patients ϩ T cells; total peripheral blood mononuclear cells (white bars) from this patient were also analyzed. Two microliters of the final TCR Vb RT-PCR product mixture were subjected to electrophoresis on a 5% polyacrylamide sequencing gel, and the resulting bands were detected on an automated sequencer. The relative amounts of Vb transcripts in cells were quantified by fluorescence analysis with Genescan software.
with HTLV-1 PM, each Vb family typically had 5-7 length variants, with 1 or 2 dense bands in the middle of the spectratype, which is consistent with a Gaussian distribution (figure 3, left panel). But in some CD8
ϩ cells from patients with HTLV-1 PM, there were marked expansions of CDR3 segments of a certain length within the given Vb family ( figure 3, center panel) .
We defined such skewed spectratype bands as "oligoclonal" when a single peak contained 150% of the total area under the spectratype curve for that Vb family ( figure 3, right panel) . In TCR spectratypes of MILs, we observed dominant peaks among TCR spectratype patterns (figure 4). The corresponding CD8 ϩ PBMC spectratype profiles were more diverse than those TCR Vb transcripts were reverse transcribed and amplified using Vb-specific and b-chain constant region (Cb)-specific primers. A 6-FAM dye-labeled Cb-specific primer was used to visualize the amplified products. The height of each peak represents the intensity of fluorescence. The horizontal axis represents the CDR3 length in base pairs of Vb-Cb elongation reaction products. Left panel, Typical Gaussian profiles found in spectratypes derived from total PBMC. Each Vb spectratype generally had 5-7 peaks, with 1 or 2 dense bands in their middle portions. Center and right panels, Monoclonal and oligoclonal spectratypes observed in some MILs. There were marked expansions of CDR3 segments of a certain length within the given Vb family. We defined such skewed spectratype bands as "oligoclonal" when the area under the corresponding peak occupied 150% of the total area in the spectratype for that Vb segment. The percentage area for a particular peak was calculated by the following formula: . (area of peak/total area of all peaks) ϫ 100 Figure 4 . Profiles of the b-chain variable region (Vb) spectratypes of a patient with human T lymphotropic virus type 1 polymyositis (patient HTLV-1 PM1). The lengths of the highest Vb1, Vb7, and Vb9 complementarity-determining region 3 (CDR3) peaks from CD8 ϩ T cells from patient HTLV-1 PM1 were exactly the same as that of the highest peak of muscle-infiltrating lymphocytes (MILs) on the same gel. In the Vb3 spectratype, the peak that was the second highest in circulating CD8 ϩ T cells was the highest in MILs. Representative results of CDR3 sequences of these clones are presented in table 3.
of MILs in most Vb families tested. However, we observed dominant peaks in MILs that had the same length as the peaks in CD8
ϩ PBMC ( figure 4 ). This suggested that oligoclonally proliferating CD8 ϩ T cells may infiltrate muscle tissue. Table  2 summarizes the TCR Vb use and clonality of all the samples tested.
Common TCR clonotype in MILs and PBMC from patients with HTLV-1 PM. To determine whether these clonally expanded CD8
ϩ T cells and MILs had the same TCR clonotype, we subcloned and sequenced RT-PCR products derived from CD8 ϩ T cells and MILs from 2 patients with HTLV-1 PM. For 1 HLA-A*02-positive patient (patient HTLV-1 PM3), we ex- ϩ T cells represent proliferation of certain Tax-specific clones [20] , it was of interest to see whether Tax11-19-specific cells were present in muscle specimens from this patient. TCR spectratyping analysis indicated that, whereas the highest peak lengths of certain Vb spectratypes derived from CD8 ϩ PBMC were clearly different from those from MILs, some TCRs showed exactly the same length between MILs and corresponding peaks of CD8 ϩ PBMC (figure 4) . We sequenced all TCR RT-PCR products in which the highest oligoclonal spectratype peak of a given Vb was the same length in MILs and either CD8 ϩ T cells or Tax11-19 tetramerpositive cells. Sequence analysis revealed that the major clonotypes seen in both T cell populations were different in most TCRs examined; however, in 1 patient (patient HTLV-1 PM1), we found that the same clonotype was present in the dominant clones of both MILs and CD8 ϩ T cells (table 3 and figure 4 ). These data show that oligoclonally proliferated CD8 ϩ T cells were present in the infiltrate in muscle tissue from this patient. For patient HTLV-1 PM2, however, we could not find any clonotype from a dominant clone of MILs that was expanded HTLV-1 PM2) . The length of the highest Vb7 and Vb13S1 complementarity-determining region 3 (CDR3) from CD8 ϩ T cells was exactly the same as the length of the highest peak of muscle-infiltrating lymphocytes (MILs) on the same gel. In the Vb6 spectratype, the peak that was the second highest in circulating CD8 ϩ T cells was the highest in MILs. The CDR3 sequence result for Vb7 is presented in table 4.
in CD8 ϩ T cells. Instead, 1 clonotype that was expanded in MILs was also observed in CD4 ϩ PBMC from this patient (table 4 and figure 5) .
Highly conserved amino acid sequences of the common TCR CDR3 in muscle tissue from an HLA-A*02-positive patient with HTLV-1 PM. A highly conserved amino acid motif, GLAG, was found in the CDR3 of common T cell clones expressing the same TCR Vb family genes, such as TCR Vb1, Vb3, and Vb6, from MILs of HLA-A*02-positive patient HTLV-1 PM3 (table 5 and figure 6 ). Most interestingly, in TCR Vb3, the dominant clonotype derived from MILs (YAGLAGGLGN) was also found in the clonotype derived from HLA-A*02/Tax11-19 tetramer-positive CD8 ϩ T cells, indicating that Tax11-19-specific CD8 ϩ T cells had infiltrated muscle tissue. Sequence analysis of TCR Vb13S1 from HLA-A*02/Tax11-19 tetramer-positive T cells showed that 3 of 4 clonotypes observed had a sequence (PGQG) that was remarkably similar to that of previously reported Tax11-19-specific clones (PGxG motif, followed by specific b-chain joining region use) [27] . The amino acid sequence "GQG" was also observed in Vb1 and Vb6 of HLA-A*02/ Tax11-19 tetramer-positive T cells from patient HTLV-1 PM3 (table 5) .
Discussion
PM and DM are chronic autoimmune diseases of unknown origin that damage systemic striated muscles; both conditions are characterized by inflammatory infiltrates, muscle weakness, and fatigue [15] . In PM, T cell-mediated cytotoxicity, rather than humoral immunity, may be the main effector mechanism, whereas in DM, antibody-mediated humoral immunity, rather than cellular immunity, is responsible for the muscle damage [15] [16] [17] . It is well known that HTLV-1 infection is associated with inflammatory involvement outside the central nervous system in patients with and patients without HAM/TSP. Epidemiological studies have shown a rate of HTLV-1 antibody positivity among patients with PM that is significantly higher than that in the general population [11, 12] . Therefore, it is possible that HTLV-1 is causally related to the pathogenesis of polymyositis in HTLV-1 seropositive individuals. To the best of our knowledge, there has been no systematic report about HTLV-1 PM and proviral load from Japan; however, Gilbert et al. [28] recently reported that all 24 of the Jamaican patients with HTLV-1 PM who they tested had high HTLV-1 antibody titers. Two of the 3 Japanese patients included in this study also had high HTLV-1 antibody titers (ϫ8192).
To understand the pathogenesis of microbial infectionassociated HTLV-1 PM, it is important to analyze whether the T cell characteristics of patients with HTLV-1 PM are similar to those of patients with either idiopathic PM or DM, 2 diseases that are not associated with infection. Immunohistochemical analysis of muscle biopsy specimens revealed that, as occurs in the spinal cords of patients with HAM/TSP, MILs from patients with HTLV-1 PM contain both CD4 ϩ and CD8 ϩ T cells, and that CD4
ϩ T cells predominated in all 3 patients tested. Because we have reported elsewhere that the HTLV-1-harboring cells in the muscle lesions of HTLV-1 PM are CD4 ϩ T cells [13] , it is more likely that HTLV-1 PM is due not to direct viral infection of the muscle fibers but, rather, to a T cell-mediated immunologic process (including CD8 ϩ T cells) that is initiated by HTLV-1 infection. Although it is not yet known, it remains possible that both CD4 ϩ and CD8 ϩ T cells (particularly CD4 T cells, which usually outnumber CD8 ϩ T cells in our patients with HTLV-1 PM) contribute to the inflammation. This was also observed in the early stages of active inflammatory lesions in patients with HAM/TSP [29] . CD4 ϩ T cells may initiate the lesions in PM and are probably more important in causing the tissue damage.
There is increasing evidence that HTLV-1-specific cytotoxic T lymphocytes play a role in the pathogenesis of HAM/TSP [30] [31] [32] [33] [34] . Indeed, we found that 1 Tax11-19-specific clonotype clonally expanded in muscle was also present in peripheral blood Tax11-19/HLA-A*02 tetramer-positive CD8 ϩ T cells from HLA-A*02-positive patient HTLV-1 PM3. Interestingly, the comparison of TCR Vb CDR3 sequences of MILs from patient HTLV-1 PM3 revealed a 4-aa GLAG motif in all clonally expanded TCR Vbs, suggesting antigen-driven stimulation by a limited number of T cell epitopes. This CDR3 motif (GLAG) was identical to that of the motif previously reported in both Fas-sensitive T cells from the labial salivary glands of patients with Sjö gren syndrome [35] and HLA-A*02/Tax11-19 peptide-specific CD8 ϩ T cells [20] . Because this motif contains amino acid residues that are important for the HLA-Tax peptide-TCR interaction [36] , it is interesting to see whether these muscle-infiltrating and GLAG motif-carrying cells have the potential to proliferate and secrete cytokines responding to Tax11-19 peptide. However, it is noteworthy that we found only 1 HTLV-1-specific clonotype in MILs, and this was not predominant in peripheral blood. Moreover, most HTLV-1-specific clonotypes that we found were expanded only in PBMC, not in MILs, which suggests that the frequency of HTLV-1-specific clonotypes in MILs from this patient (HTLV-1 PM3) was low. Another motif, PGQG, was only found in Tax11-19/HLA-A*02 tetramer-positive CD8 ϩ T cells in PBMC but not in MILs. These results suggest that Tax11-19-specific clones did not play a major part in inflammatory response in this patient. On the other hand, we analyzed TCR spectratyping and clonotypes of CD4 ϩ T cells and CD8 ϩ T cells in PBMC from HLA-A*02-negative patients HTLV-1 PM1 and HTLV-1 PM2 and compared the results with those for MILs. For patient HTLV-1 PM1, some expanded clonotypes seen in MILs were also found in PBMC, which indicates that a similarity to idiopathic PM exists. In contrast, there was no major clonotype of the same length that was common to both MILs and CD8 ϩ PBMC in patient HTLV-1 PM2, which suggests that HTLV-1 PM and idiopathic PM have different pathology.
Although there is no good evidence that Tax-specific T cells cross-react with a self-antigen, the possibility that such a mechanism exists is difficult to exclude, particularly because a putative cross-reacting self-peptide could differ markedly in sequence from the Tax peptide(s) [37] . Because a clonally expanded Tax11-19-specific clonotype was found in MILs from patient HTLV-1 PM3 (although the frequency was low), the Tax protein is likely to be expressed in HTLV-1-infected CD4 ϩ T cells, as has been observed in patients with HAM/TSP [38] . These invasive and Tax-specific CD8 ϩ T cells, as well as Tax-specific CD4 ϩ T cells, may have the potential to cause damage to the muscle, as well as other tissues. If this is the case, Tax-specific T cells could damage tissues by a bystander mechanism-it is not necessary to invoke a cross-reaction with a putative self-antigen. It is also possible that, if there is a low frequency of invasion of muscle by T cells, then, by chance, an invading T cell might come from a minority population in PBMC. Local expansion of this clone in the inflamed muscle, driven either by HTLV-1 antigens or possibly self-antigens, will then result in a spectrum of TCR Vb use that differs from that of PBMC.
In conclusion, we first demonstrated that some T cell clonotypes, including 1 Tax11-19-specific clonotype observed in PBMC from patients with HTLV-1 PM, were oligoclonally expanded in MILs, although most T cell clonotypes from MILs were not found in PBMC. The results of the present study suggest that the restricted T cell clones expanded in the muscle lesion participate in the pathogenesis of HTLV-1 PM. However, because the origin (CD4 or CD8) of clonotypes expanded in MILs and the CDR3 amino acid motif conservation pattern differed from patient to patient, the pathogenic mechanism of HTLV-1 PM might not be simple, presumably because PM observed in HTLV-1-seropositive subjects may include both idiopathic PM and PM induced or modulated by HTLV-1.
